These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38086857)

  • 1. Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa.
    Scalabrino ML; Thapa M; Wang T; Sampath AP; Chen J; Field GD
    Nat Commun; 2023 Dec; 14(1):8256. PubMed ID: 38086857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa.
    Scalabrino ML; Thapa M; Wang T; Sampath AP; Chen J; Field GD
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
    Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
    Elife; 2021 Apr; 10():. PubMed ID: 33847261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust cone-mediated signaling persists late into rod photoreceptor degeneration.
    Scalabrino ML; Thapa M; Chew LA; Zhang E; Xu J; Sampath AP; Chen J; Field GD
    Elife; 2022 Aug; 11():. PubMed ID: 36040015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Michalakis S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Schulze E; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Mühlfriedel R; Biel M
    Adv Exp Med Biol; 2014; 801():733-9. PubMed ID: 24664765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPGR-associated retinal degeneration in human X-linked RP and a murine model.
    Huang WC; Wright AF; Roman AJ; Cideciyan AV; Manson FD; Gewaily DY; Schwartz SB; Sadigh S; Limberis MP; Bell P; Wilson JM; Swaroop A; Jacobson SG
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5594-608. PubMed ID: 22807293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Txnip Gene Therapy of Retinitis Pigmentosa Improves Cone Health.
    Xue Y
    Adv Exp Med Biol; 2023; 1415():143-146. PubMed ID: 37440027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
    Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
    Elife; 2021 Jun; 10():. PubMed ID: 34184634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa.
    Fernández-Sánchez L; Lax P; Isiegas C; Ayuso E; Ruiz JM; de la Villa P; Bosch F; de la Rosa EJ; Cuenca N
    Hum Gene Ther; 2012 Dec; 23(12):1290-300. PubMed ID: 23017108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors.
    Tan MH; Smith AJ; Pawlyk B; Xu X; Liu X; Bainbridge JB; Basche M; McIntosh J; Tran HV; Nathwani A; Li T; Ali RR
    Hum Mol Genet; 2009 Jun; 18(12):2099-114. PubMed ID: 19299492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa.
    Jong ED; Hacibekiroglu S; Guo L; Sawula E; Li B; Li C; Ho MT; Shoichet MS; Wallace VA; Nagy A
    Stem Cell Res Ther; 2023 Aug; 14(1):212. PubMed ID: 37605279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model.
    Cammalleri M; Dal Monte M; Locri F; Pecci V; De Rosa M; Pavone V; Bagnoli P
    J Cell Mol Med; 2019 Aug; 23(8):5176-5192. PubMed ID: 31251468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success of Gene Therapy in Late-Stage Treatment.
    Koch SF; Tsang SH
    Adv Exp Med Biol; 2018; 1074():101-107. PubMed ID: 29721933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones.
    Karademir D; Todorova V; Ebner LJA; Samardzija M; Grimm C
    BMC Biol; 2022 Apr; 20(1):86. PubMed ID: 35413909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
    Barone I; Novelli E; Strettoi E
    Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight vision repair by cell transplantation.
    Santos-Ferreira T; Postel K; Stutzki H; Kurth T; Zeck G; Ader M
    Stem Cells; 2015 Jan; 33(1):79-90. PubMed ID: 25183393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG assessment of altered retinal function in canine models of retinitis pigmentosa and monitoring of response to translatable gene augmentation therapy.
    Pasmanter N; Occelli LM; Petersen-Jones SM
    Doc Ophthalmol; 2021 Oct; 143(2):171-184. PubMed ID: 33818677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa.
    Wang SK; Xue Y; Rana P; Hong CM; Cepko CL
    Proc Natl Acad Sci U S A; 2019 May; 116(20):10140-10149. PubMed ID: 31036641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.